454 related articles for article (PubMed ID: 30840032)
1. Development and Validation of a Risk Prediction Model for In-Hospital Mortality Among Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis-ABCD-10.
Noe MH; Rosenbach M; Hubbard RA; Mostaghimi A; Cardones AR; Chen JK; Cotliar J; Davis MDP; Dominguez A; Fox LP; Hughey LC; Kaffenberger BH; Kroshinsky D; Kwong BY; Miller DD; Musiek A; Ortega-Loayza AG; Sharon VR; Shinkai K; Summers EM; Wanat KA; Wetter DA; Worswick S; Margolis DJ; Gelfand JM; Micheletti RG
JAMA Dermatol; 2019 Apr; 155(4):448-454. PubMed ID: 30840032
[TBL] [Abstract][Full Text] [Related]
2. Comparing the Accuracy of ABCD-10 and SCORTEN in Predicting the In-Hospital Mortality of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis: A Multi-Institutional Study from Central China.
Suo H; Jiang B; Sun X; Dong J; Alamgir M; Guan X; Su H; Liu Y; Xia Y; Zhou N; Feng A; Tao J
Dermatology; 2022; 238(4):736-744. PubMed ID: 34875648
[TBL] [Abstract][Full Text] [Related]
3. Assessment and Comparison of Performance of ABCD-10 and SCORTEN in Prognostication of Epidermal Necrolysis.
Koh HK; Fook-Chong S; Lee HY
JAMA Dermatol; 2020 Dec; 156(12):1294-1299. PubMed ID: 33084873
[TBL] [Abstract][Full Text] [Related]
4. Performance of ABCD-10 and SCORTEN mortality prediction models in a cohort of patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Duplisea MJ; Roberson ML; Chrisco L; Strassle PD; Williams FN; Ziemer CM
J Am Acad Dermatol; 2021 Oct; 85(4):873-877. PubMed ID: 33940101
[TBL] [Abstract][Full Text] [Related]
5. Cohort study of patients with Stevens-Johnson syndrome and toxic epidermal necrolysis in China: evaluation of risk models and new predictor of pulmonary consolidation on computed tomography.
Shou Y; Yang L; Yang Y; Zhu X; Li F; Yin B; Zheng Y; Xu J
Front Med; 2021 Aug; 15(4):585-593. PubMed ID: 33644844
[TBL] [Abstract][Full Text] [Related]
6. Improvement of Mortality Prognostication in Patients With Epidermal Necrolysis: The Role of Novel Inflammatory Markers and Proposed Revision of SCORTEN (Re-SCORTEN).
Koh HK; Fook-Chong SMC; Lee HY
JAMA Dermatol; 2022 Feb; 158(2):160-166. PubMed ID: 34935871
[TBL] [Abstract][Full Text] [Related]
7. How Does SCORTEN Score?
Zavala S; O'Mahony M; Joyce C; Baldea AJ
J Burn Care Res; 2018 Jun; 39(4):555-561. PubMed ID: 29789855
[TBL] [Abstract][Full Text] [Related]
8. RDW-SD and PCT Are Potential Prognostic Factors for In-hospital Death in Patients With Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis.
Zhang L; Lan Y; Qi B; Shuai P; Hou Q; Liu W; Wang Q
Allergy Asthma Immunol Res; 2023 Nov; 15(6):812-824. PubMed ID: 37957797
[TBL] [Abstract][Full Text] [Related]
9. SCORTEN: a severity-of-illness score for toxic epidermal necrolysis.
Bastuji-Garin S; Fouchard N; Bertocchi M; Roujeau JC; Revuz J; Wolkenstein P
J Invest Dermatol; 2000 Aug; 115(2):149-53. PubMed ID: 10951229
[TBL] [Abstract][Full Text] [Related]
10. Ophthalmic Manifestations of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis and Relation to SCORTEN.
Morales ME; Purdue GF; Verity SM; Arnoldo BD; Blomquist PH
Am J Ophthalmol; 2010 Oct; 150(4):505-510.e1. PubMed ID: 20619392
[TBL] [Abstract][Full Text] [Related]
11. Clinical value of the prognostic nutritional index and red blood cell distribution width-to-albumin ratio for the prediction of severity of and mortality associated with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Zhang Z; Yu K; Jiang Z; Liu O; Wan C; Wu H; Cao X
J Dermatol; 2023 Apr; 50(4):518-524. PubMed ID: 36478458
[TBL] [Abstract][Full Text] [Related]
12. Accuracy of SCORTEN and ABCD-10 to predict mortality and the influence of renal function in Stevens-Johnson syndrome/toxic epidermal necrolysis.
Torres-Navarro I; Briz-Redón Á; Botella-Casas G; Sahuquillo-Torralba A; Calle-Andrino A; de Unamuno-Bustos B; Piqueras-García J; Roca Ginés J; Magdaleno Tapial J; Alegre de Miquel V; Botella-Estrada R
J Dermatol; 2020 Oct; 47(10):1182-1186. PubMed ID: 32856355
[TBL] [Abstract][Full Text] [Related]
13. A clinicotherapeutic analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis with an emphasis on the predictive value and accuracy of SCORe of Toxic Epidermal Necrolysis.
Bansal S; Garg VK; Sardana K; Sarkar R
Int J Dermatol; 2015 Jan; 54(1):e18-26. PubMed ID: 25534407
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27-year retrospective study.
Oen IM; van der Vlies CH; Roeleveld YW; Dokter J; Hop MJ; van Baar ME
J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2444-50. PubMed ID: 26416341
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of histologic features of toxic epidermal necrolysis.
Valeyrie-Allanore L; Bastuji-Garin S; Guégan S; Ortonne N; Bagot M; Roujeau JC; Revuz JE; Wechsler J; Wolkenstein P
J Am Acad Dermatol; 2013 Feb; 68(2):e29-35. PubMed ID: 22088428
[TBL] [Abstract][Full Text] [Related]
16. SCORTEN accurately predicts mortality among toxic epidermal necrolysis patients treated in a burn center.
Cartotto R; Mayich M; Nickerson D; Gomez M
J Burn Care Res; 2008; 29(1):141-6. PubMed ID: 18182912
[TBL] [Abstract][Full Text] [Related]
17. Pediatric toxic epidermal necrolysis: using SCORTEN and predictive models to predict morbidity when a focus on mortality is not enough.
Beck A; Quirke KP; Gamelli RL; Mosier MJ
J Burn Care Res; 2015; 36(1):167-77. PubMed ID: 25559731
[TBL] [Abstract][Full Text] [Related]
18. Mortality and risk factors on admission in toxic epidermal necrolysis: A cohort study of 59 patients.
Watanabe T; Go H; Saigusa Y; Takamura N; Watanabe Y; Yamane Y; Totsuka M; Ishikawa H; Nakamura K; Matsukura S; Kambara T; Takaki S; Yamaguchi Y; Aihara M
Allergol Int; 2021 Apr; 70(2):229-234. PubMed ID: 33279401
[TBL] [Abstract][Full Text] [Related]
19. Toxic epidermal necrolysis and Stevens-Johnson syndrome in South Africa: a 3-year prospective study.
Kannenberg SM; Jordaan HF; Koegelenberg CF; Von Groote-Bidlingmaier F; Visser WI
QJM; 2012 Sep; 105(9):839-46. PubMed ID: 22543685
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil : lymphocyte ratio is associated with disease severity and mortality in patients with Stevens-Johnson syndrome/toxic epidermal necrolysis.
Wang Q; Lan YP; Qi B; Yin L; Zhang LX; Liu W
J Dermatol; 2021 Sep; 48(9):1394-1400. PubMed ID: 34060656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
